Search: Aurora

ACB FINAL DEADLINE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Aurora Cannabis Inc. Investors of Important Tuesday Deadline in Securities Class Action; Expanded Class Period – ACB

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between October 23, 2018 and January 6, 2020, inclusive (the “Class Period”) of the important January 21, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.…

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Files Securities Class Action Complaint against Aurora Cannabis (ACB) and Its Senior Executives Extending Period of Alleged False Statements: Firm Urges Aurora Cannabis (ACB) Investors With $500k+ Losses To Contact Its Attorneys As Application Deadline Looms

Hagens Berman has filed a class action Complaint on behalf of investors in Aurora Cannabis Inc. (NYSE: ACB). The firm urges ACB investors who have suffered losses in excess of $500,000 to submit their losses now to learn if they qualify to recover their investment losses. READ MORE: https://finance.yahoo.com/news/hagens-berman-national-trial-attorneys-234400171.html?.tsrc=rss

Aurora Cannabis Stock Falls as Analysts Raise Concerns About Balance Sheet

(ACB) stock’s struggles continued on Friday after two analysts lowered their ratings, citing concerns about the strength of the pot grower’s balance sheet. Aurora stock (ticker: ACB) is down 22% in the new year and has fallen 74% over the past 12 months. Two separate analysts recently called Aurora’s financial strength into question. READ MORE: https://finance.yahoo.com/m/8393a07e-ae6c-36d3-b55c-31f351ca65f6/aurora-cannabis-stock-falls.html?.tsrc=rss

Aurora Cannabis stock tumbles toward 2 1/2-year low after another analyst turns bearish

The U.S.-listed shares of Aurora Cannabis Inc. tumbled 7.5% toward a 2 1/2-year low in morning trading Friday, after BofA Securities analyst Christopher Carey turned bearish on the Canada-based cannabis company, citing balance sheet concerns and a lack of visibility “on several fronts.” Post cut his rating to underperform, after being at neutral for the past six months, and slashed…